<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta
      name="viewport"
      content="width=
    , initial-scale=1.0"
    />
    <title>Document</title>

    <link rel="stylesheet" href="style.css" />
  </head>
  <body>
    <div class="header-info">
      <ul>
        <li>
          <p>CORRESPONDENCE</p>
        </li>
        <li>|</li>
        <li>
          <p class="date">NOV 13, 2024</p>
        </li>
        <li>|</li>
        <li>
          <p class="tier">FREE</p>
        </li>
      </ul>
    </div>

    <div class="header">
      <ul>
        <li>
          <h2>
            Activity of Research-Grade Pemivibart against SARS-CoV-2 Sublineages
          </h2>
        </li>
        <li>
          <img src="./img/chart.png" alt="" />
        </li>
      </ul>

      <p class="author">Q. Wang and Others</p>
    </div>

    <div class="body">
      <p class="content">
        SARS-CoV-2 continues to evolve under immunologic pressure. A synthesized
        version of pemivibart, an antiâ€“SARS-CoV-2 monoclonal antibody with
        recent emergency-use authorization, showed mixed activity against
        emerging variants.
      </p>
    </div>

    <div class="footer">
      <p>
        <bold>Correction</bold> Pemivibart Activity against Recent SARS-CoV-2
        JN.1 Sublineages
      </p>
    </div>
  </body>
</html>
